Subscribe
hynci-istockphoto-com-dollars-cash-
hynci / iStockphoto.com
13 August 2018Americas

PhRMA members invested $71.4bn in R&D in 2017

Members of the Pharmaceutical Research and Manufacturers of America (PhRMA) last year obtained the highest-ever level of investment for the industry group, recording $71.4 billion of funding in research and development (R&D).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.
Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.
Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

More on this story

Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.
Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York